• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载毛果芸香碱的壳聚糖/卡波姆纳米粒的表征

Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.

作者信息

Kao Huei-Jen, Lin Hong-Ru, Lo Yu-Li, Yu Shi-Ping

机构信息

Department of Pharmacy, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.

出版信息

J Pharm Pharmacol. 2006 Feb;58(2):179-86. doi: 10.1211/jpp.58.2.0004.

DOI:10.1211/jpp.58.2.0004
PMID:16451745
Abstract

Patients using ophthalmic drops are faced with frequent dosing schedules and difficult drop instillation. Therefore, a long-lasting pilocarpine-loaded chitosan (CS)/Carbopol nanoparticle ophthalmic formulation was developed. The physicochemical properties of the prepared nanoparticles were investigated using dynamic light scattering, zeta-potential, transmission electron microscopy, Fourier transform infrared ray spectroscopy (FT-IR) and differential scanning calorimetry (DSC). The sustained-release effects of pilocarpine-loaded nanoparticles were evaluated using in-vitro release and in-vivo miotic tests, and compared with pilocarpine in solution, gel and liposomes. We found that the prepared nanoparticles were about 294 nm in size. DSC and FT-IR studies suggested that an electrostatic interaction between CS and Carbopol contributes at least in part to the stabilization of pilocarpine/CS/Carbopol nanoparticles. When compared with pilocarpine in solution, gel or liposomes, the best slow-release profile of pilocarpine from the prepared nanoparticles occurred in a dissolution test. In the in-vivo miotic study, pilocarpine-loaded CS/Carbopol nanoparticles showed the most significant long-lasting decrease in the pupil diameter of rabbits. The advantages of CS and Carbopol are good biocompatibility, biodegradability and low toxicity. CS is also a mucoadhesive polymer. Thus, pilocarpine/CS/Carbopol nanoparticles may provide an excellent potential alternative ophthalmic sustained-release formulation of pilocarpine for clinical use. CS/Carbopol nanoparticles may also be useful for a variety of other therapeutic delivery systems.

摘要

使用眼药水的患者面临着频繁给药方案和滴眼困难的问题。因此,开发了一种负载毛果芸香碱的壳聚糖(CS)/卡波姆纳米颗粒眼用制剂。使用动态光散射、zeta电位、透射电子显微镜、傅里叶变换红外光谱(FT-IR)和差示扫描量热法(DSC)研究了制备的纳米颗粒的物理化学性质。使用体外释放和体内缩瞳试验评估了负载毛果芸香碱纳米颗粒的缓释效果,并与溶液、凝胶和脂质体中的毛果芸香碱进行了比较。我们发现制备的纳米颗粒尺寸约为294nm。DSC和FT-IR研究表明,CS和卡波姆之间的静电相互作用至少部分有助于毛果芸香碱/CS/卡波姆纳米颗粒的稳定。与溶液、凝胶或脂质体中的毛果芸香碱相比,在溶出试验中,制备的纳米颗粒中毛果芸香碱的缓释曲线最佳。在体内缩瞳研究中,负载毛果芸香碱的CS/卡波姆纳米颗粒使兔子瞳孔直径的持久减小最为显著。CS和卡波姆的优点是良好的生物相容性、生物降解性和低毒性。CS也是一种粘膜粘附聚合物。因此,毛果芸香碱/CS/卡波姆纳米颗粒可能为临床使用提供一种极好的潜在替代毛果芸香碱眼用缓释制剂。CS/卡波姆纳米颗粒也可能对多种其他治疗递送系统有用。

相似文献

1
Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.载毛果芸香碱的壳聚糖/卡波姆纳米粒的表征
J Pharm Pharmacol. 2006 Feb;58(2):179-86. doi: 10.1211/jpp.58.2.0004.
2
Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery.用于眼部给药的载毛果芸香碱壳聚糖-聚丙烯酸纳米混悬液
J Biomater Sci Polym Ed. 2007;18(2):205-21. doi: 10.1163/156856207779116739.
3
[Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate].[用于硝酸毛果芸香碱的壳聚糖包衣眼用亚微乳剂]
Yao Xue Xue Bao. 2011 Aug;46(8):990-6.
4
Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate.自组装六方液晶凝胶作为新型眼部制剂,增强硝酸毛果芸香碱的局部递送。
Int J Pharm. 2019 May 1;562:31-41. doi: 10.1016/j.ijpharm.2019.02.033. Epub 2019 Mar 14.
5
Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.用于将酒石酸溴莫尼定可控递送至眼膜的壳聚糖纳米颗粒。
Pharmazie. 2011 Aug;66(8):594-9.
6
Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery.载壳聚糖-卵清蛋白纳米粒的卡波姆凝胶经皮传递醋氯芬酸。
Colloids Surf B Biointerfaces. 2014 Feb 1;114:36-44. doi: 10.1016/j.colsurfb.2013.09.045. Epub 2013 Sep 30.
7
In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.用于盐酸毛果芸香碱缓释眼部给药的原位凝胶化木葡聚糖制剂。
Int J Pharm. 2001 Oct 23;229(1-2):29-36. doi: 10.1016/s0378-5173(01)00825-0.
8
High pH tolerance of a chitosan-PAA nanosuspension for ophthalmic delivery of pilocarpine.壳聚糖-PAA 纳米混悬液对匹鲁卡品眼部给药的高 pH 值耐受性。
J Biomater Sci Polym Ed. 2010;21(2):141-57. doi: 10.1163/156856209X410274.
9
Chitosan matrix with three dimensionally ordered macroporous structure for nimodipine release.壳聚糖基三维有序大孔结构载尼莫地平释放系统
Carbohydr Polym. 2012 Nov 6;90(4):1648-55. doi: 10.1016/j.carbpol.2012.07.045. Epub 2012 Jul 25.
10
A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.基于液晶纳米粒子的潜在载体用于硝酸毛果芸香碱的眼部递药。
Int J Pharm. 2013 Oct 15;455(1-2):75-84. doi: 10.1016/j.ijpharm.2013.07.057. Epub 2013 Jul 31.

引用本文的文献

1
An Update on Novel Drug Delivery Systems for the Management of Glaucoma.用于青光眼治疗的新型药物递送系统的最新进展
Pharmaceutics. 2025 Aug 21;17(8):1087. doi: 10.3390/pharmaceutics17081087.
2
Chitosan Nanoparticles: Approaches to Preparation, Key Properties, Drug Delivery Systems, and Developments in Therapeutic Efficacy.壳聚糖纳米颗粒:制备方法、关键特性、药物递送系统及治疗效果的进展
AAPS PharmSciTech. 2025 Apr 17;26(5):108. doi: 10.1208/s12249-025-03100-z.
3
Research progress of nano delivery systems for intraocular pressure lowering drugs.
降眼压药物纳米递送系统的研究进展
Heliyon. 2024 Jun 12;10(12):e32602. doi: 10.1016/j.heliyon.2024.e32602. eCollection 2024 Jun 30.
4
Chitosan/carbomer nanoparticles- laden in situ gel for improved ocular delivery of timolol: in vitro, in vivo, and ex vivo study.载有壳聚糖/卡波姆纳米颗粒的原位凝胶用于改善噻吗洛尔的眼部给药:体外、体内和离体研究。
Drug Deliv Transl Res. 2025 Apr;15(4):1210-1220. doi: 10.1007/s13346-024-01663-1. Epub 2024 Jul 8.
5
Nanoparticles for the treatment of glaucoma-associated neuroinflammation.用于治疗青光眼相关神经炎症的纳米颗粒。
Eye Vis (Lond). 2022 Jul 2;9(1):26. doi: 10.1186/s40662-022-00298-y.
6
Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia Management.用于高脂血症治疗的普伐他汀载药纳米凝胶的制剂开发与评价
Gels. 2022 Jan 28;8(2):81. doi: 10.3390/gels8020081.
7
In Silico Screening and In Vivo Evaluation of Potential CACNA2D1 Antagonists as Intraocular Pressure-Reducing Agents in Glaucoma Therapy.青光眼治疗中作为降眼压药物的潜在CACNA2D1拮抗剂的计算机模拟筛选和体内评价
Pharmaceuticals (Basel). 2021 Aug 31;14(9):887. doi: 10.3390/ph14090887.
8
Nanochitosan: Commemorating the Metamorphosis of an ExoSkeletal Waste to a Versatile Nutraceutical.纳米壳聚糖:纪念一种外骨骼废弃物向多功能营养保健品的蜕变。
Nanomaterials (Basel). 2021 Mar 23;11(3):821. doi: 10.3390/nano11030821.
9
Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions.对抗青光眼的新型药物递送系统:制剂障碍与解决方案
Pharmaceutics. 2020 Dec 26;13(1):28. doi: 10.3390/pharmaceutics13010028.
10
Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.纳米技术在医学和外科青光眼治疗中的应用综述
Adv Ther. 2020 Jan;37(1):155-199. doi: 10.1007/s12325-019-01163-6. Epub 2019 Dec 10.